mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |